Technical Analysis for ATXI - Avenue Therapeutics, Inc.

Grade Last Price % Change Price Change
F 4.64 1.98% 0.09
ATXI closed up 1.98 percent on Thursday, April 22, 2021, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical ATXI trend table...

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Slingshot Bearish Bearish Swing Setup 1.98%
Stochastic Buy Signal Bullish 1.98%
Lower Bollinger Band Walk Weakness 1.98%
Outside Day Range Expansion 1.98%
Wide Bands Range Expansion 1.98%
Lower Bollinger Band Touch Weakness 1.98%
Older End-of-Day Signals for ATXI ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High about 17 hours ago
Down 3% about 17 hours ago
Down 2 % about 17 hours ago
Down 1% about 17 hours ago
Up 5% about 17 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Avenue Therapeutics, Inc. Description

Avenue Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in acquiring, licensing, developing and commercializing products principally for use in the acute or intensive care hospital setting. Its product candidate is intravenous (IV) Tramadol, an intravenous formulation of tramadol hydrochloride (HCl), for the management of moderate to moderately severe postoperative pain. Tramadol, a synthetic dual-acting opioid, is a centrally acting analgesic with weak opioid agonist properties. It also works via the inhibition of serotonin and noradrenaline re-uptake and blocking nociceptive impulses at the spinal level. Tramadol is also combined with acetaminophen (APAP) or nonsteroidal anti-inflammatory drugs (NSAIDS) in clinical practice. During the year ending December 31, 2016, the Company had completed a pharmacokinetics (PK) study for IV Tramadol in healthy volunteers.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Drugs Chemical Compounds Chloride Opioid Amines Analgesics Neurochemistry Hepatotoxins Pharmacokinetics Paracetamol Nonsteroidal Anti Inflammatory Drug

Is ATXI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 12.3398
52 Week Low 2.85
Average Volume 339,971
200-Day Moving Average 7.02
50-Day Moving Average 5.82
20-Day Moving Average 5.60
10-Day Moving Average 5.09
Average True Range 0.63
ADX 21.79
+DI 16.24
-DI 26.02
Chandelier Exit (Long, 3 ATRs ) 5.65
Chandelier Exit (Short, 3 ATRs ) 5.74
Upper Bollinger Band 7.42
Lower Bollinger Band 3.79
Percent B (%b) 0.23
BandWidth 64.81
MACD Line -0.45
MACD Signal Line -0.26
MACD Histogram -0.1863
Fundamentals Value
Market Cap 77.71 Million
Num Shares 16.7 Million
EPS -1.96
Price-to-Earnings (P/E) Ratio -2.37
Price-to-Sales 0.00
Price-to-Book 17.30
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.27
Resistance 3 (R3) 5.26 5.04 5.17
Resistance 2 (R2) 5.04 4.88 5.05 5.13
Resistance 1 (R1) 4.84 4.78 4.94 4.85 5.09
Pivot Point 4.62 4.62 4.67 4.63 4.62
Support 1 (S1) 4.42 4.46 4.52 4.43 4.19
Support 2 (S2) 4.20 4.36 4.21 4.15
Support 3 (S3) 4.00 4.20 4.12
Support 4 (S4) 4.01